Delta4’s CEO, Kurt Herpel, and CSO, Klaus Kratochwill, were recently featured on the PharmaVentures podcast, where they discussed how Delta4 […]
Category: Miscellaneous
The Role of Drug Combination in Modern Medicine: Delta4’s Innovative Approach
The use of multiple active ingredients in medicine is a time-honored practice, with roots stretching back to Traditional Chinese Medicine […]
Delta4: A Trusted Partner in EU Horizon Research Projects
Delta4 is proud to announce its participation in two significant EU Horizon research projects: PICKED (Personalized Medicine in Chronic Kidney […]
Leveraging Multi-Omics Data for Drug Repurposing and Discovery at Delta4
At Delta4, we leverage multi-omics data to identify novel drug repurposing opportunities by uncovering molecular similarities between diseases and existing […]
The Path to New Therapies for Focal Segmental Glomerulosclerosis (FSGS)
Developing new treatments for complex diseases presents a myriad of challenges, ranging from understanding the disease’s mechanisms to ensuring the […]
What to Expect From The Pharmaceutical Industry In 2024
As we step into 2024, the pharmaceutical industry stands at the cusp of remarkable advancements and significant transformations. This year […]
Advancing Healthcare Through Drug Discovery Services: Unleashing the Power of Innovation
In the realm of healthcare, the journey from a promising drug idea to an effective therapy is not a straightforward […]
What is Drug Discovery? Unveiling the Process, Challenges, and Future
In the intricate world of healthcare, the journey of a drug from a basic idea to a therapy that can […]
Understanding the Drug Discovery Pipeline: From the Lab to the Patient
The world of pharmaceuticals is complex and layered. At the heart of this realm is the drug discovery pipeline, a […]
The Transformative Role of AI in Pharma – An Exploration
What is Artificial Intelligence? Artificial Intelligence (AI) is a field of computer science that aims to mimic human intelligence, enabling […]